Ruggeri et al. showed in a major mismatch HCT murine model that alloreactive Ly49 ligand-mismatched NK cell infusion prevented T cell-induced GvHD, while administration of even large numbers of non-alloreactive Ly49 ligand-matched NK cells provided no protection (3). This evidence concerns the gene KLRA1P and graft versus host disease.